Markets:

Overview

News

Currencies

International

Treasuries

TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

49.81 +0.53 (+1.08%)

Streaming Delayed Price Updated: 10:47 AM EDT, Aug 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TG Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review ↗

August 09, 2024

After Monday's panicked global sell-off, markets have calmed down.

Via Investor's Business Daily

NASDAQ:TGTX is showing decent growth, but is still valued reasonably. ↗

August 07, 2024

NASDAQ:TGTX stands out as a growth opportunity that won't break the bank.

Via Chartmill

S&P 500 Surges Over 2%; Caterpillar Earnings Beat Estimates ↗

August 06, 2024

Via Benzinga

Topics Earnings Stocks

Crude Oil Moves Higher; Yum! Brands Posts Upbeat Earnings ↗

August 06, 2024

Via Benzinga

$1000 Invested In TG Therapeutics 5 Years Ago Would Be Worth This Much Today ↗

July 12, 2024

Via Benzinga

(TGTX) - Analyzing TG Therapeutics's Short Interest ↗

June 04, 2024

Via Benzinga

Peering Into TG Therapeutics's Recent Short Interest ↗

May 14, 2024

Via Benzinga

(TGTX) - Analyzing TG Therapeutics's Short Interest ↗

March 13, 2024

Via Benzinga

TGTX Stock Earnings: TG Therapeutics Beats EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

TGTX stock results show that TG Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday ↗

August 06, 2024

Via Benzinga

TG Therapeutics Stock Jumps As Surprise Profit Smashes Views By 157% ↗

August 06, 2024

The company unexpectedly reported profit in the second quarter, handily beating views for a per-share loss.

Via Investor's Business Daily

In the world of growth stocks, NASDAQ:TGTX shines as a value proposition. ↗

July 11, 2024

Looking for growth without the hefty price tag? Consider TG THERAPEUTICS INC (NASDAQ:TGTX).

Via Chartmill

"Rule Breaker Investing" Market Cap Game Show: Bill Mann vs. Bill Barker ↗

June 27, 2024

Our first-ever twin bill.

Via The Motley Fool

Earnings Preview For TG Therapeutics ↗

February 27, 2024

Via Benzinga

How Is The Market Feeling About TG Therapeutics? ↗

February 16, 2024

Via Benzinga

Nasdaq 100 Overbought? Here’s What History Says About The Current Rally ↗

June 26, 2024

Find out the historical patterns traders can look for to anticipate the next move in the Nasdaq 100.

Via Talk Markets

The Most Shorted Stocks in June: Hold, Short, or Squeeze?

June 18, 2024

Given the proper catalyst, the short interest in these stocks may lead to a short squeeze. All the market needs is a push and it may come at any time.

Via MarketBeat

Why TG Therapeutics Stock Was Rocketing Higher This Week ↗

May 03, 2024

The company raised guidance for sales of its drug for relapsing multiple sclerosis.

Via The Motley Fool

TGTX Stock Earnings: TG Therapeutics Misses EPS, Beats Revenue for Q1 2024 ↗

May 01, 2024

TGTX stock results show that TG Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

TG Therapeutics stock just rallied 30%: what happened? ↗

May 01, 2024

TG Therapeutics Inc (NASDAQ: TGTX) is up 30% on Wednesday even though it reported a wider-than-expected per-share loss for its fiscal first quarter.

Via Talk Markets

Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises

June 11, 2024

EQNX::TICKER_START (NASDAQ:TLSA),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:BIIB),(NASDAQ:TGTX) EQNX::TICKER_END

Via FinancialNewsMedia

Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday ↗

May 01, 2024

Via Benzinga

Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises

June 11, 2024

From FN Media Group LLC

Via GlobeNewswire

Why Is Multiple Sclerosis-Focused TG Therapeutics Stock Trading Higher Today? ↗

February 28, 2024

TG Therapeutics exceeds expectations with Q4 2023 revenues of $43.97M. Briumvi's success in the U.S., Europe launch, and new patents drive optimism. TGTX shares surge

Via Benzinga

Topics Intellectual Property

Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 01, 2024

Via Benzinga

TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares? ↗

February 28, 2024

The company reported in-line sales for the fourth quarter, but shares soared by double digits.

Via Investor's Business Daily

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 28, 2024

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

Via Benzinga

Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday ↗

February 28, 2024

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Wednesday.

Via Benzinga

Topics Stocks

Earnings Scheduled For February 28, 2024 ↗

February 28, 2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

February 26, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.